Skip to main content

Table 4 The distrubution of received therapies in concordant and discordant results

From: Systemic therapy response evaluation in prostate carcinoma with [68Ga]Ga-PSMA-11 PET/CT

  Result of [68Ga]Ga-PSMA-11 and serum PSA Total
Concordant Discordant
Received Treatment First-line hormone therapy 14 3 17
82.4% 17.6% 100%
Docetaxel 17 4 21
81% 19% 100%
Abiraterone 2 1 3
66.7% 33.3% 100%
Enzalutamide 2 1 3
66.7% 33.3% 100%
Cabazitaxel 1 2 3
33.3% 66.7% 100%
[177Lu]Lu-PSMA-617 3 0 3
100% 0% 100%
Total 39 11 50
78% 22% 100%